Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on May 20, 2009

Cardiovascular Research, doi:10.1093/cvr/cvp160
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
83/4/737    most recent
cvp160v2
cvp160v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kang, Y.-M.
Right arrow Articles by Francis, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, Y.-M.
Right arrow Articles by Francis, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.

Brain tumor necrosis factor-{alpha} modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure

Yu-Ming Kang1,2,3,a,*, Rong-Li He3,a, Li-Min Yang3, Da-Nian Qin1, Anuradha Guggilam2, Carrie Elks2, Ning Yan3, Zheng Guo3 and Joseph Francis2,*

1 Shantou University Medical College, Shantou 515041, China
2 Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, LA 70803, USA
3 Shanxi Medical University, Taiyuan 030001, China

* Corresponding author: Joseph Francis, B.V.Sc, M.V.Sc, PhD, Comparative Biomedical Sciences, School of Veterinary, Medicine, Louisiana State University, Baton Rouge, LA 70803, USA, Phone: +1 225 578 9752, Fax: +1 225 578 9895, jfrancis{at}lsu.edu, or Yu-Ming Kang, MD, PhD, Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA, Phone: +1 225 578 9550, Fax: +1 225 578 9895, ymkang{at}lsu.edu

Aims: Increased proinflammatory cytokines after myocardial infarction augment the progression of heart failure (HF) and are of prognostic significance. Recently, we demonstrated that increased proinflammatory cytokines in the brains of HF rats increased paraventricular nucleus superoxide and down-regulated neuronal nitric oxide synthase (nNOS), contributing to sympathoexcitation. In this study, we explored the possible roles of brain proinflammatory cytokines and their effects on modulating paraventricular nucleus neurotransmitters in the exaggerated sympathetic activity in HF.

Methods: Sprague-Dawley rats with HF or sham-operated control (SHAM) rats were treated for 4 weeks with a continuous intracerebroventricular (ICV) infusion of the cytokine blockers, pentoxifylline (PTX, 10 µg/h and 40 µg/h) or etanercept (ETN, 5µg/h and 10 µg/h), or vehicle. Another set of HF and SHAM rats were treated with intraperitoneal (IP) infusion of a similar dose of PTX or ETN.

Results: HF rats had increased neuronal excitation accompanied by higher levels of glutamate, norepinephrine (NE) and tyrosine hydroxylase (TH), and lower levels of {gamma}-aminobutyric acid (GABA), nNOS and 67-kDa isoform of glutamate decarboxylase (GAD67) compared to SHAM rats. Plasma cytokines, NE, epinephrine, angiotensin II, and renal sympathetic nerve activity were also increased in HF rats. ICV treatment with low doses of PTX or ETN attenuated, and high doses prevented, the increased glutamate, NE and TH and decreased GABA, nNOS and GAD67 in the PVN and renal sympathetic nerve activity of HF rats. IP treatment with similar doses of PTX or ETN did not affect glutamate, NE, TH, GABA, nNOS and GAD67 in the paraventricular nucleus and had no effect on renal sympathetic nerve activity of HF rats.

Conclusion: This study, for the first time, demonstrates that proinflammatory cytokines modulate neurotransmitters in the paraventricular nucleus and contribute to sympathoexcitation in HF.

KEYWORDS neurotransmitters; paraventricular nucleus of hypothalamus; cytokines; sympathetic nervous system; heart failure


Time for primary review: 26 Days

a Both authors contributed equally to this study.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.